Stemina Launches Autism Clinical Study
Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum disorder (ASD) ever conducted. The Children’s Autism Metabolome Project or “CAMP” study will enroll 1,500 subjects from six sites across the country. CAMP will attempt to confirm that sets of metabolic biomarkers can detect subtypes of ASD.
- Beth Donley and Bob Burrier are excited to be exhibitors at the National @tacanow #Autism Conference in #Atlanta,… https://t.co/Bncq5Ktp1I2 days ago
- Spotlight on our Resources page, full of helpful content for parents. Learn more about how to handle picky eating,… https://t.co/UarRolP5Dq3 days ago
- Sometimes children with #autism act in ways that could be harmful to themselves or others. If a child is secluded o… https://t.co/OJuzLLBwHD3 days ago